Guizhou Xinbang Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -6.64% vs -4.78% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 817.78% vs -115.44% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,263.40",
          "val2": "1,353.30",
          "chgp": "-6.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "77.10",
          "val2": "34.50",
          "chgp": "123.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.30",
          "val2": "2.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "64.60",
          "val2": "-9.00",
          "chgp": "817.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "61.00%",
          "val2": "-13.90%",
          "chgp": "7.49%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -6.85% vs -6.62% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 23.19% vs -55.99% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,607.40",
          "val2": "6,019.80",
          "chgp": "-6.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "449.40",
          "val2": "498.30",
          "chgp": "-9.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "19.30",
          "val2": "24.40",
          "chgp": "-20.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-12.70",
          "val2": "-2.40",
          "chgp": "-429.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "191.80",
          "val2": "155.70",
          "chgp": "23.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "41.80%",
          "val2": "44.00%",
          "chgp": "-0.22%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,263.40

1,353.30

-6.64%

Operating Profit (PBDIT) excl Other Income

77.10

34.50

123.48%

Interest

3.30

2.20

50.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

64.60

-9.00

817.78%

Operating Profit Margin (Excl OI)

61.00%

-13.90%

7.49%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -6.64% vs -4.78% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 817.78% vs -115.44% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

5,607.40

6,019.80

-6.85%

Operating Profit (PBDIT) excl Other Income

449.40

498.30

-9.81%

Interest

19.30

24.40

-20.90%

Exceptional Items

-12.70

-2.40

-429.17%

Consolidate Net Profit

191.80

155.70

23.19%

Operating Profit Margin (Excl OI)

41.80%

44.00%

-0.22%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -6.85% vs -6.62% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 23.19% vs -55.99% in Dec 2024

All Annual Results